Differential Effects of Antihypertensive Treatment on Left Ventricular Diastolic Function. An ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Substudy

Journal of the American College of Cardiology

Volumn 55, Issue 17, 2010, Pages 1875-1881

  Tapp, Robyn J ^a,b   Sharp, Andrew ^a   Stanton, Alice V ^c   O'Brien, Eoin ^d   Chaturvedi, Nishi ^a   Poulter, Neil R ^a   Sever, Peter S ^a   Thom, Simon A McG ^a   Hughes, Alun D ^a   Mayet, Jamil ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

antihypertension treatment; left ventricular diastolic function; tissue Doppler echocardiography

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BRAIN NATRIURETIC PEPTIDE; PERINDOPRIL;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; VENTRICULAR FUNCTION, LEFT;

EID: 77950904358     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.11.084     Document Type: Article

References (32)

1. Haider A.W., Larson M.G., Franklin S.S., and Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 138 (2003) 10-16
2. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
3. Carson P., Massie B.M., McKelvie R., et al. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail 11 (2005) 576-585
4. Kapuku G.K., Seto S., Mori H., et al. Impaired left ventricular filling in borderline hypertensive patients without cardiac structural changes. Am Heart J 125 (1993) 1710-1716
5. Sagie A., Benjamin E.J., Galderisi M., et al. Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (the Framingham Heart Study). Am J Cardiol 72 (1993) 662-665
6. Marabotti C., Genovesi-Ebert A., Palombo C., Giaconi S., Michelassi C., and Ghione S. Echo-Doppler assessment of left ventricular filling in borderline hypertension. Am J Hypertens 2 (1989) 891-897
7. Shapiro L.M., and McKenna W.J. Left ventricular hypertrophy. Relation of structure to diastolic function in hypertension. Br Heart J 51 (1984) 637-642
8. Muller-Brunotte R., Kahan T., Malmqvist K., Ring M., and Edner M. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). Am J Hypertens 19 (2006) 927-936
9. Solomon S.D., Janardhanan R., Verma A., et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 369 (2007) 2079-2087
10. Yu C.M., Sanderson J.E., Marwick T.H., and Oh J.K. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 49 (2007) 1903-1914
11. Okura H., Takada Y., Kubo T., et al. Tissue Doppler-derived index of left ventricular filling pressure, E/E′, predicts survival of patients with non-valvular atrial fibrillation. Heart 92 (2006) 1248-1252
12. Hillis G.S., Moller J.E., Pellikka P.A., et al. Noninvasive estimation of left ventricular filling pressure by E/e′ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43 (2004) 360-367
13. McMahon C.J., Nagueh S.F., Pignatelli R.H., et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 109 (2004) 1756-1762
14. Dahlof B., Sever P.S., Poulter N.R., et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366 (2005) 895-906
15. Stanton A., Fitzgerald D., Hughes A., et al. An intensive phenotyping study to enable the future examination of genetic influences on hypertension-associated cardiovascular disease. J Hum Hypertens 15 (2001) S13-S18
16. Jarnert C., Mejhert M., Ring M., Persson H., and Edner M. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique. Eur J Heart Fail 2 (2000) 151-160
17. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
18. Yeo K.T., Wu A.H., Apple F.S., et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 338 (2003) 107-115
19. Williams B., Poulter N.R., Brown M.J., et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 18 (2004) 139-185
20. Aurigemma G.P., Gottdiener J.S., Shemanski L., Gardin J., and Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 37 (2001) 1042-1048
21. Kamp O., Sieswerda G.T., and Visser C.A. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. Am J Cardiol 92 (2003) 344-348
22. Moller J.E., Dahlstrom U., Gotzsche O., et al. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. Am Heart J 147 (2004) 494-501
23. Diez J., Gonzalez A., Lopez B., Ravassa S., and Fortuno M.A. Effects of antihypertensive agents on the left ventricle: clinical implications. Am J Cardiovasc Drugs 1 (2001) 263-279
24. Schiffrin E.L., Pu Q., and Park J.B. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens 15 (2002) 105-110
25. Fountoulaki K., Dimopoulos V., Giannakoulis J., Zintzaras E., and Triposkiadis F. Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan. Am J Hypertens 18 (2005) 171-177
26. Ilgenli T.F., Kilicaslan F., Kirilmaz A., and Uzun M. Bisoprolol improves echocardiographic parameters of left ventricular diastolic function in patients with systemic hypertension. Cardiology 106 (2006) 127-131
27. Agabiti-Rosei E., Trimarco B., Muiesan M.L., et al. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 23 (2005) 1091-1098
28. Garcia M.J., Thomas J.D., and Klein A.L. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32 (1998) 865-875
29. Boyer J., Thanigaraj S., Schechtman K., and Perez J. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93 (2003) 870-875
30. Solomon S.D., Janardhanan R., Verma A., et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 369 (2007) 2079-2087
31. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
32. Senn S. Baseline balance and valid statistical analyses: common misunderstandings. Appl Clin Trials 14 (2005) 24-27